Wikipedia - Rabeprazole
Rabeprazole is an antiulcer drug in the class of proton pump inhibitors. It was developed by Eisai Co. and is marketed by Janssen-Cilag as rabeprazole sodium under the brand names AcipHex (English pronunciation: /'æs?f?ks/, referring to pH) in the US and Pariet in Australia, Brazil, Canada, Japan, and Russia.
[edit] Indications and usageShort-term treatment in healing and symptomatic relief of duodenal ulcers and erosive or ulcerative gastroesophageal reflux disease (GERD); maintaining healing and reducing relapse rates of heartburn symptoms in patients with GERD; treatment of daytime and nighttime heartburn and other symptoms associated with GERD; long-term treatment of pathological hypersecretory conditions, including Zollinger-Ellison syndrome and in combination with amoxicillin and clarithromycin to eradicate Helicobacter pylori.
[edit] Contraindications
[edit] Restriction of usage
[edit] Side effectsRabeprazole adverse reactions/side effects include[citation needed]:
[edit] Drug interactionsRabeprazole decreases the concentration of ketoconazole in the plasma (in 33%), increases the concentration of digoxin (in 22%), and does not interact with liquid antacids. Rabeprazole is compatible with any medicine metabolized by the CYP450 (theophylline, warfarin, diazepam, phenytoin). [edit] OverdosageThere is no available data on symptoms of rabeprazole overdose. [edit] Formulations and brand namesRabeprazole as Rablet (Lupin), AcipHex, Rabeloc, Pariet is supplied in:
Rabeprazole is sold under the brand names Razo, Parit, and Rablet in India, and Zechin in Pakistan. In the Indian rural market Rabiloz is being marketed by Torrent Pharmaceuticals Ltd. [edit] References
[edit] External links
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Rabeprazole". |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||




